Recent Advances in Impurity Profiling of Active Pharmaceutical Ingredients

Every drug that's active has some contamination. These contaminations appear during the preparation of the drug or come from unwanted corridors that are present along with the main drug during the mixing or storage process. In the drug assiduity, contaminants are anything that isn't part of the drug and comes from the timber process or is left behind unintentionally. Both how pure a drug is and the types of contaminations it has are important in the drug field, and they're needed by the rules set by the authorities. According to guidelines from the International Council for Harmonization, checking for contamination through analysis is necessary and needed before a new drug can be approved for trade. Having contamination in a drug can affect the quality of the product. contaminations can be of different types, like organic and inorganic, and can come from starting accoutrements, intermediate way, by-products, or breakdown products. Special styles should be used to find and measure any contaminations that are further than 0.1. By chancing, relating, and measuring these contaminations, we can make a drug that's safer and has lower dangerous goods.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-15
DOI
https://doi.org/10.5281/zenodo.17360508
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent Advances in Impurity Profiling of Active Pharmaceutical Ingredients

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
article

Recent Advances in Impurity Profiling of Active Pharmaceutical Ingredients

article en

Abstract

Every drug that's active has some contamination. These contaminations appear during the preparation of the drug or come from unwanted corridors that are present along with the main drug during the mixing or storage process. In the drug assiduity, contaminants are anything that isn't part of the drug and comes from the timber process or is left behind unintentionally. Both how pure a drug is and the types of contaminations it has are important in the drug field, and they're needed by the rules set by the authorities. According to guidelines from the International Council for Harmonization, checking for contamination through analysis is necessary and needed before a new drug can be approved for trade. Having contamination in a drug can affect the quality of the product. contaminations can be of different types, like organic and inorganic, and can come from starting accoutrements, intermediate way, by-products, or breakdown products. Special styles should be used to find and measure any contaminations that are further than 0.1. By chancing, relating, and measuring these contaminations, we can make a drug that's safer and has lower dangerous goods.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 35%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recent Advances in Impurity Profiling of Active Pharmaceutical Ingredients · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS